CY1119899T1 - Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρηση - Google Patents
Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρησηInfo
- Publication number
- CY1119899T1 CY1119899T1 CY20181100162T CY181100162T CY1119899T1 CY 1119899 T1 CY1119899 T1 CY 1119899T1 CY 20181100162 T CY20181100162 T CY 20181100162T CY 181100162 T CY181100162 T CY 181100162T CY 1119899 T1 CY1119899 T1 CY 1119899T1
- Authority
- CY
- Cyprus
- Prior art keywords
- glucosaminoglycans
- recoverable
- underground
- medical use
- disc unit
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161577223P | 2011-12-19 | 2011-12-19 | |
| PCT/SE2012/051433 WO2013095279A1 (en) | 2011-12-19 | 2012-12-19 | Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119899T1 true CY1119899T1 (el) | 2018-06-27 |
Family
ID=48668970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181100162T CY1119899T1 (el) | 2011-12-19 | 2018-02-09 | Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρηση |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9475888B2 (enExample) |
| EP (1) | EP2794665B1 (enExample) |
| JP (2) | JP6543467B2 (enExample) |
| KR (1) | KR102135485B1 (enExample) |
| CN (1) | CN104144950B (enExample) |
| AU (1) | AU2012354229B2 (enExample) |
| BR (1) | BR112014014454B1 (enExample) |
| CA (1) | CA2856492C (enExample) |
| CL (1) | CL2014001651A1 (enExample) |
| CO (1) | CO7061069A2 (enExample) |
| CY (1) | CY1119899T1 (enExample) |
| DK (1) | DK2794665T3 (enExample) |
| ES (1) | ES2656613T3 (enExample) |
| HR (1) | HRP20180124T1 (enExample) |
| HU (1) | HUE036523T2 (enExample) |
| IL (1) | IL232905A (enExample) |
| LT (1) | LT2794665T (enExample) |
| ME (1) | ME02994B (enExample) |
| MX (1) | MX351104B (enExample) |
| NO (1) | NO2904345T3 (enExample) |
| PL (1) | PL2794665T3 (enExample) |
| PT (1) | PT2794665T (enExample) |
| RS (1) | RS56874B1 (enExample) |
| RU (1) | RU2617764C2 (enExample) |
| SI (1) | SI2794665T1 (enExample) |
| SM (1) | SMT201800143T1 (enExample) |
| WO (1) | WO2013095279A1 (enExample) |
| ZA (1) | ZA201403640B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| EP2830635A4 (en) * | 2012-03-26 | 2016-03-16 | Dilafor Ab | COMBINATION TREATMENT OF ILLUSTRATED SULFATED GLYCOSAMINOGLYCANES |
| CN104244957B (zh) * | 2012-03-26 | 2017-11-17 | 迪乐方有限责任公司 | 用于治疗分娩停止的方法 |
| UA117912C2 (uk) * | 2012-05-08 | 2018-10-25 | Ділафор Аб | Застосування гепарину або гепарансульфату для лікування післяпологової кровотечі (ппк) |
| GB2515315A (en) * | 2013-06-19 | 2014-12-24 | Dilafor Ab | New Processes |
| CN103788222B (zh) * | 2014-01-08 | 2016-08-31 | 中国科学院昆明植物研究所 | Fuc3S4S取代的低聚糖胺聚糖及其制备方法 |
| EP3137509A4 (en) * | 2014-04-30 | 2018-03-14 | Agency For Science, Technology And Research | Heparan sulphates |
| CN108424474B (zh) * | 2017-02-15 | 2023-07-25 | 清华大学 | 去抗凝肝素衍生物及其用于炎症性肠病的治疗 |
| UA129730C2 (uk) | 2020-02-17 | 2025-07-16 | Дилафор Аб | Тафоксипарин для лікування прееклампсії |
| EP4272749A1 (en) | 2022-05-03 | 2023-11-08 | Dilafor AB | New medical use of tafoxiparin |
| JP2025514038A (ja) | 2022-05-03 | 2025-05-02 | ディラフォール アクチエボラグ | タフォキシパリンの新規な医学的使用 |
| GB202407366D0 (en) * | 2024-05-23 | 2024-07-10 | Glycos Biomedical Ltd | Preparation of medium molecular weight heparin |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1136620A (en) | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
| JPS63246396A (ja) * | 1987-03-31 | 1988-10-13 | Shiseido Co Ltd | モノクロ−ナル抗体 |
| FR2614026B1 (fr) * | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
| SE9002550D0 (sv) * | 1990-08-01 | 1990-08-01 | Kabivitrum Ab | Heparinfragment |
| SE9003181D0 (sv) | 1990-10-04 | 1990-10-04 | Kabivitrum Ab | Use of heparin fraction |
| US5250519A (en) | 1991-03-29 | 1993-10-05 | Glycomed Incorporated | Non-anticoagulant heparin derivatives |
| US5280016A (en) | 1991-03-29 | 1994-01-18 | Glycomed Incorporated | Non-anticoagulant heparin derivatives |
| JPH0532703A (ja) * | 1991-07-26 | 1993-02-09 | Terumo Corp | 低分子量ヘパリン誘導体の製造法 |
| AU5442594A (en) * | 1992-10-13 | 1994-05-09 | Virginia Commonwealth University | Use of non-anticoagulant heparin for treating ischemia/reperfusion injury |
| US5527785A (en) | 1993-05-14 | 1996-06-18 | The Regents Of The University Of California | Selectin receptor modulating compositions |
| US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
| ATE224918T1 (de) * | 1995-03-31 | 2002-10-15 | Hamilton Civic Hospitals Res | Zusammensetzung zur hemmung der thromboseentstehung |
| US5993810A (en) | 1996-03-15 | 1999-11-30 | Lebovitz; Shamir Israel | Method of softening or ripening the cervix of a female mammal using collagenase |
| US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
| WO1998016559A1 (fr) | 1996-10-15 | 1998-04-23 | Toray Industries, Inc. | Agent de maturation des canaux cervicaux |
| GB9711443D0 (en) * | 1997-06-03 | 1997-07-30 | Leo Pharm Prod Ltd | Chemical suppositions |
| JP3342007B2 (ja) * | 1997-11-20 | 2002-11-05 | 郁男 山科 | 低分子ヘパリン修飾体及び皮膚潰瘍治療剤 |
| US6596705B1 (en) | 1998-02-09 | 2003-07-22 | The Regents Of The University Of California | Inhibition of L-selectin and P-selection mediated binding using heparin |
| US6498246B1 (en) | 1998-02-26 | 2002-12-24 | Seikagaku Corporation | Glycosaminoglycan derivatives and processes for preparing same |
| US6028061A (en) | 1998-06-18 | 2000-02-22 | Children's Medical Center Corp | Angiogenesis inhibitors and use thereof |
| EP1022289B1 (en) * | 1998-07-31 | 2004-07-07 | Seikagaku Corporation | Novel glycosaminoglycan and drug compositions containing the same |
| JP2002523522A (ja) * | 1998-08-26 | 2002-07-30 | ザ コラボレイティブ グループ，リミテッド． | 非誘導化水溶性ベータ−（１，３）−グルカンのレセプター |
| MXPA02000142A (es) * | 1999-06-30 | 2003-07-21 | Hamilton Civic Hospitals Res | Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo. |
| JP4897991B2 (ja) * | 1999-07-23 | 2012-03-14 | ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ | 超低分子量ヘパリン組成物 |
| IT1316986B1 (it) | 2000-01-25 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica. |
| JP4585072B2 (ja) * | 2000-02-29 | 2010-11-24 | 扶桑薬品工業株式会社 | ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物 |
| DK1319183T3 (da) * | 2000-09-12 | 2009-05-18 | Massachusetts Inst Technology | Fremgangsmåder og produkter relateret til heparin med lav molekylvægt |
| SE521676C2 (sv) | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
| US20040072796A1 (en) | 2002-04-18 | 2004-04-15 | Embury Stephen H. | Method and composition for preventing pain in sickle cell patients |
| US8071569B2 (en) | 2002-09-20 | 2011-12-06 | Mousa Shaker A | Oxidized heparin fractions and their use in inhibiting angiogenesis |
| JP2005106694A (ja) * | 2003-09-30 | 2005-04-21 | Mochida Pharmaceut Co Ltd | 敗血症早期検出及び重篤度評価 |
| EP1582531A1 (en) | 2004-03-24 | 2005-10-05 | Aventis Pharma S.A. | Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products |
| US20060040896A1 (en) * | 2004-08-18 | 2006-02-23 | Paringenix, Inc. | Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity |
| US7741311B2 (en) | 2005-01-03 | 2010-06-22 | Shaker Mousa | Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing |
| MX2008000974A (es) * | 2005-07-22 | 2008-03-27 | Univ California | Composiciones de heparina e inhibicion de selectina. |
| WO2007014155A2 (en) | 2005-07-22 | 2007-02-01 | Trf Pharma, Inc. | Method for treating sickle cell disease and sickle cell disease sequelae |
| AU2007233320B2 (en) * | 2006-04-04 | 2013-12-12 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| CN101495517B (zh) * | 2006-05-25 | 2012-10-10 | 莫曼塔医药品有限公司 | 低分子量肝素及其用途 |
| WO2009007224A1 (en) | 2007-07-10 | 2009-01-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Low molecular weight heparin derivatives having neuroprotective activity |
| EP2205642B1 (en) | 2007-11-02 | 2016-01-27 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
| US8592393B2 (en) * | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| WO2009059283A1 (en) * | 2007-11-02 | 2009-05-07 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
| US8445436B2 (en) | 2007-12-03 | 2013-05-21 | Florida State University Research Foundation, Inc. | Oxytocin and melatonin compositions and associated methods for inducing labor |
| CN102177180A (zh) | 2008-04-04 | 2011-09-07 | 犹他州大学研究基金会 | 烷基化半合成的糖胺聚糖醚及其制备和使用方法 |
| WO2010111570A1 (en) * | 2009-03-27 | 2010-09-30 | E. I. Du Pont De Nemours And Company | Polyglycerol aldehydes |
| EP2419736B1 (en) | 2009-04-16 | 2014-01-29 | Momenta Pharmaceuticals, Inc. | Methods of assessing activity of a polysaccharide composition |
| US20120108538A1 (en) | 2009-06-30 | 2012-05-03 | James Beeson | Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity |
| CA2769258A1 (en) * | 2009-07-31 | 2011-02-03 | Bayer Healthcare Llc | Modified factor ix polypeptides and uses thereof |
| BR112012015029A2 (pt) * | 2009-12-22 | 2017-06-27 | Lifebond Ltd | matriz reticulada, método para controlar a formação de uma matriz, método ou matriz, método para vedar um tecido contra vazamento de um fluído corporal, agente hemostático ou vedante cirúrgico, composição para vedar um ferimento, uso da composição, composição para um veículo para entrega localizada de fármaco, composição para engenharia de tecido, e método para modificar uma composição |
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| CN104244957B (zh) | 2012-03-26 | 2017-11-17 | 迪乐方有限责任公司 | 用于治疗分娩停止的方法 |
| EP2830635A4 (en) | 2012-03-26 | 2016-03-16 | Dilafor Ab | COMBINATION TREATMENT OF ILLUSTRATED SULFATED GLYCOSAMINOGLYCANES |
-
2012
- 2012-12-19 ES ES12858809.2T patent/ES2656613T3/es active Active
- 2012-12-19 HU HUE12858809A patent/HUE036523T2/hu unknown
- 2012-12-19 PT PT128588092T patent/PT2794665T/pt unknown
- 2012-12-19 JP JP2014547146A patent/JP6543467B2/ja active Active
- 2012-12-19 DK DK12858809.2T patent/DK2794665T3/da active
- 2012-12-19 LT LTEP12858809.2T patent/LT2794665T/lt unknown
- 2012-12-19 AU AU2012354229A patent/AU2012354229B2/en active Active
- 2012-12-19 PL PL12858809T patent/PL2794665T3/pl unknown
- 2012-12-19 CN CN201280062050.1A patent/CN104144950B/zh active Active
- 2012-12-19 HR HRP20180124TT patent/HRP20180124T1/hr unknown
- 2012-12-19 SM SM20180143T patent/SMT201800143T1/it unknown
- 2012-12-19 RS RS20180155A patent/RS56874B1/sr unknown
- 2012-12-19 KR KR1020147016676A patent/KR102135485B1/ko active Active
- 2012-12-19 US US14/366,624 patent/US9475888B2/en active Active
- 2012-12-19 RU RU2014129816A patent/RU2617764C2/ru active
- 2012-12-19 MX MX2014007122A patent/MX351104B/es active IP Right Grant
- 2012-12-19 ME MEP-2018-14A patent/ME02994B/me unknown
- 2012-12-19 SI SI201231138T patent/SI2794665T1/en unknown
- 2012-12-19 CA CA2856492A patent/CA2856492C/en active Active
- 2012-12-19 WO PCT/SE2012/051433 patent/WO2013095279A1/en not_active Ceased
- 2012-12-19 EP EP12858809.2A patent/EP2794665B1/en active Active
- 2012-12-19 BR BR112014014454-0A patent/BR112014014454B1/pt active IP Right Grant
-
2013
- 2013-09-27 NO NO13771071A patent/NO2904345T3/no unknown
-
2014
- 2014-05-20 ZA ZA2014/03640A patent/ZA201403640B/en unknown
- 2014-06-01 IL IL232905A patent/IL232905A/en active IP Right Grant
- 2014-06-16 CO CO14129964A patent/CO7061069A2/es unknown
- 2014-06-19 CL CL2014001651A patent/CL2014001651A1/es unknown
-
2018
- 2018-02-09 CY CY20181100162T patent/CY1119899T1/el unknown
- 2018-02-28 JP JP2018034714A patent/JP2018111825A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119899T1 (el) | Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρηση | |
| CY1120197T1 (el) | Ηπαρινες χαμηλης αντιπηκτικης δρασης | |
| CY1124718T1 (el) | Ανθεκτικο στη διασπαση υαλουρονικο χαμηλου μοριακου βαρους με σταυροδεσμους | |
| CY1119660T1 (el) | Antibakthpiakh απο toy στοματος συνθεση | |
| CY1119113T1 (el) | Σκευασματα με βαση το υαλουρονικο οξυ | |
| CY1118223T1 (el) | Μεθοδοι θεραπειας του διαβητη με ανταγωνιστες toy dll4 | |
| MX344236B (es) | Hidrolizado de colageno para usarse para mejorar la salud de la piel, el cabello y/o uñas de un humano. | |
| TN2010000086A1 (en) | Antiviral composition comprising a sulfated polysaccharide | |
| CY1118222T1 (el) | Συνθεσεις λυασης φαινυλαλανινης αμμωνιας προκαρυωτικων και μεθοδοι αγωγης καρκινου χρησιμοποιωντας συνθεσεις εξ' αυτης | |
| CY1118934T1 (el) | Παρασκευη ενεργης ακρως φωσφορυλιωμενης ανθρωπινης ν-ακετυλογαλακτοζαμινης-6-σουλφατασης και χρησεις αυτης | |
| CY1111354T1 (el) | Συστασεις αναστολεα ddp iv | |
| MA32394B1 (fr) | Composes pegyles d'insuline lispro | |
| CY1114960T1 (el) | Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου | |
| EA201190283A1 (ru) | Мультивалентный адъювантный дисплей | |
| MY149505A (en) | Hyaluronic acid binary mixtures and therapeutic use thereof | |
| EA201290941A1 (ru) | КОНЪЮГИРОВАННЫЙ ФАКТОР СВЕРТЫВАНИЯ КРОВИ VIIa | |
| BR112012019844A2 (pt) | metodos e composições para melhorar a resistência mecânica dos dentes | |
| NZ624749A (en) | A sulfated polysaccharide compound and the preparation and use thereof | |
| TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
| CR20110552A (es) | Tratamiento de transtornos resistentes a la insulina | |
| CY1115780T1 (el) | Φαρμακευτικη συνθεση με glycosαμινοglycans και χρηση αυτης για την θεραπεια χρονιων ελκων | |
| PH12014501290A1 (en) | Methods and products to diagnose and treat heatiness | |
| CY1113469T1 (el) | Συνθεσεις για την θεραπεια μιας φλεγμονωδους παθησης αυτο-ανοσιας | |
| TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
| BR112013009185A2 (pt) | uso de mexiprostil no tratamento de doença inflamatória intestinal e/ou de síndrome do intestino irritável. |